Bone Cancer Oncology Treatment
Appleglc.com guides bone cancer patients through osteosarcoma and Ewing sarcoma treatment — with expert resources on doxorubicin, denosumab, NTRK inhibitors, and multimodal therapy planning.
Adriamycin
Doxorubicin Hydrochloride
Platinol
Cisplatin
Paraplatin
Carboplatin
Ifex
Ifosfamide
Gemzar
Gemcitabine Hydrochloride
Taxotere
Docetaxel
Taxol
Paclitaxel
Abraxane
Paclitaxel Protein-Bound Particles
Eloxatin
Oxaliplatin
Camptosar
Irinotecan Hydrochloride
Hycamtin
Topotecan Hydrochloride
Keytruda
Pembrolizumab
Opdivo
Nivolumab
Avastin
Bevacizumab
Nexavar
Sorafenib
Sutent
Sunitinib Malate
Votrient
Pazopanib Hydrochloride
Cometriq
Cabozantinib-S-Malate
Cabometyx
Cabozantinib-S-Malate
Yondelis
Trabectedin
Denosumab
Denosumab
Xgeva
Denosumab
Prolia
Denosumab
Zometa
Zoledronic Acid
Aredia
Pamidronate Disodium
Vitrakvi
Larotrectinib Sulfate
Rozlytrek
Entrectinib
Retevmo
Selpercatinib
Gavreto
Pralsetinib
Augtyro
Repotrectinib
Nivolumab SC
Nivolumab and Hyaluronidase-nvhy
Pembrolizumab IV
Pembrolizumab
Durvalumab IV
Durvalumab
Tecentriq
Atezolizumab
Imfinzi
Durvalumab
Mifamurtide
Mifamurtide
Sorafenib
Sorafenib Tosylate
Methotrexate
Methotrexate Sodium
Vincristine
Vincristine Sulfate
Etoposide
Etoposide